Read + Share
Conboy CB, Yonkus JA, Buckarma EH, Mun DG, et al. LCK inhibition downregulates YAP activity and is therapeutic in patient-derived
models of cholangiocarcinoma. J Hepatol 2022 Sep 23. pii: S0168-8278(22)03121.
PMID: 36162702
|
 |
|
Conboy CB, Yonkus JA, Buckarma EH, Mun DG, et al. LCK inhibition downregulates YAP activity and is therapeutic in patient-derived
models of cholangiocarcinoma. J Hepatol 2022 Sep 23. pii: S0168-8278(22)03121.
PMID: 36162702
|
|
|
|